| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.12 | 8e-05 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | -0.11 | 8e-05 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | -0.12 | 9e-05 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | -0.12 | 9e-05 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.11 | 9e-05 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0001 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0001 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0001 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0001 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0002 |